FAP and cancer: In the interim analysis of this prospective exploratory trial, the biodistribution of 68Ga-FAPi-46 PET correlated strongly with FAP expression in cancer versus normal tissues across 7 different cancer types, supporting its potential role as a pancancer predictive biomarker for FAP-targeted therapies.